Cucurbitacins from Ecballium elaterium juice increase the binding of bilirubin and ibuprofen to albumin in human plasma

Chemico-Biological Interactions

Volumn 169, Issue 1, 2007, Pages 53-62

  Greige Gerges, Hélène ^a   Khalil, Rony Abou ^a   Mansour, Eliane Abou ^b   Magdalou, Jacques ^c   Chahine, Ramez ^d   Ouaini, Naïm ^a  

^a HOLY SPIRIT UNIVERSITY OF KASLIK USEK   (Lebanon)

^b UNIVERSITY OF NEUCHÂTEL   (Switzerland)

^c Biopôle de l Université de Lorraine   (France)

^d LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Albumin; Bilirubin; Cucurbitacin; Ecballium elaterium; Elaterium; Ibuprofen; Jaundice; Plasma

Indexed keywords

ALBUMIN; BILIRUBIN; BILIRUBIN GLUCURONIDE; CUCURBITACIN B; CUCURBITACIN D; CUCURBITACIN E; CUCURBITACIN GLYCOSIDE; CUCURBITACIN I; ECBALLIUM ELATERIUM EXTRACT; IBUPROFEN; LIPID; MINERAL; PROTEIN; SUGAR; UNCLASSIFIED DRUG;

ARTICLE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BINDING SITE; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; LIQUID CHROMATOGRAPHY; NONHUMAN; PLASMA; PROTEIN STRUCTURE;

BILIRUBIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CUCURBITACEAE; HUMANS; HYDROGEN-ION CONCENTRATION; IBUPROFEN; PLANT EXTRACTS; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; TITRIMETRY; TRITERPENES;

ANIMALIA; ECBALLIUM ELATERIUM; RATTUS;

EID: 34447280594     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.05.003     Document Type: Article

References (43)

1. Elayan H.H., Garaibeh M.N., Zmeili S.M., and Salhab S.A. Effects of Ecballium elaterium juice on serum bilirubin concentration in male rats. Int. J. Crude Drug Res. 27 (1989) 227-234
2. Khalil A.M., and Qaoud K.M. Toxicity and partial characterization of Ecballium elaterium fruit juice. Int. J. Pharmacogn. 31 (1993) 135-141
3. Attard E.G., and Sciluna-Spiteri A. Ecballium elaterium: an in vitro source of cucurbitacins. Fitoterapia 72 (2001) 46-53
4. Rao M.M., Meshulam H., and Lavie D. The constituents of Ecballium elaterium L. Part XXIII. Cucurbitacins and hexanorcucurbitacins. J. Chem. Soc. Perkin I (1974) 2552-2556
5. Chen J.C., Chiu M.H., Nie R.L., Cordell G.A., and Qiu S.X. Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat. Prod. Rep. 22 (2005) 386-399
6. Toker G., Memisoglu M., Toker M.C., and Yesilada E. Callus formation and cucurbitacin B accumulation in Ecballium elaterium callus cultures. Fitoterapia 74 (2003) 618-623
7. Seger C., Sturm S., Mair M.E., Ellmerer E., and Stuppner H. Spectral assignments and reference data. Magn. Reson. Chem. 43 (2005) 489-491
8. Seifert K., and Elgamal M.H.A. New cucurbitacin glucosides from Ecballium elaterium L. Pharmazie 32 (1997) 605-606
9. Chakravarty A.K., Sarkar T., Das B., Masuda K., and Shiojima K. Triterpenoids Glycosides from fruits of Ecballium elaterium. J. Indian Chem. Soc. 74 (1997) 858-863
10. Yesilada E., Tanaka S., Sezik E., and Tabata M. Isolation of anti-inflammatory principle from the fruit juice of Ecballium elaterium. J. Nat. Prod. 51 (1988) 504-508
11. Agil M.A., Risco S., Miro M., Navarro M.C., Ocete M.A., and Jiménez J. Analgesic and antipyretic effects of Ecballium elaterium (L.) A. Richard. Extract in rodents. Phytother. Res. 9 (1995) 135-138
12. Khatib S.Y., Mahmoud I., and Hasan Z.A. Effects of crude Ecballium elaterium juice on isolated rabbit heart. Int. J. Pharmacogn. 31 (1993) 259-268
13. Kloutsos G., Balatsouras D.G., Kaberos A.C., Kandiloros D., Ferekidis E., and Economou C. Upper airway edema resulting from use of Ecballium elaterium. Laryngoscope 111 (2001) 1652-1655
14. Eray O., Tuncok Y., Eray E., Gunerli A., and Guven H. Severe uvular angioedema caused by intranasal administration of Ecballium elaterium. Vet. Hum. Toxicol. 41 (1999) 376-378
15. Raikhlin-Eisenkraft B., and Bentur Y. Ecballium elaterium (squirting cucumber)-remedy or poison?. J. Toxicol. Clin. Toxicol. 38 (2000) 305-308
16. Agil A., Miro M., Jimenez J., Aneriros J., Caracuel M.D., Garcia-Granados A., and Navarro M.C. Isolation of na antihepatotoxic principle from the juice of Ecballium elaterium. Planta Med. 65 (1999) 673-675
17. Blaskovich M.A., Sun J., Cantor A., Turkson J., Jove R., and Sebti S.M. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63 (2003) 1270-1279
18. Sun J., Blaskovich M.A., Jove R., Livingston S.K., Coppola D., and Sebti S.M. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24 (2005) 3236-3245
19. Recio M.C., Prieto M., Bonucelli M., Osri C., Giner R.M., Cerda-Nicolas M., and Rios J.L. Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia Tayuya roots. Planta Med. 79 (2004) 414-420
20. Duncan K.L., Duncan M.D., Alley M.C., and Sausville E.A. Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem. Pharmacol. 52 (1996) 1553-1560
21. Bartalis J., and Halaweish F.T. Relationship between cucurbitacins reversed-phase high-performance liquid chromatography hydrophobicity index and basal cytotoxicity on HepG2 cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 818 (2005) 159-166
22. Brodersen R. Bilirubin. J. Biol. Chem. 254 (1979) 2364-2369
23. Ostrow J.D., Pascolo L., Brites D., and Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol. Med. 10 (2004) 65-70
24. Ostrow J.D., Mukerjee P., and Tiribelli C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J. Lipid Res. 35 (1994) 1715-1737
25. Sudlow G., Birkett D.J., and Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11 (1975) 824-832 Peters
26. Peters T. All About Albumin: Biochemistry, Genetics, and Medical Applications (1996) 79-116
27. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reactions. J. Biol. Chem. 177 (1949) 751-766
28. Knight J., Anderson S., and Rawle J. Chemical basis of the sulfo-phospho-vanillin reaction for estimating total serum lipids. Clin. Chem. 18 (1972) 199-203
29. Législation communautaire en vigueur 79/796/CEE, portant sur la fixation des méthodes d'analyses communautaires pour le contrôle de certains sucres destinés à l'alimentation animale, 1979. pp. 24-52.
30. Doumas B.T., Kwok-Cheung P.P., Perry B.W., Jendrzejczak B., McComb R.B., Schaffer R., and Hause L.L. Candidate reference method for determination of total bilirubin in serum: development and validation. Clin. Chem. 31 (1985) 1779-1789
31. Mullon C., and Langer R. Determination of conjugated and total bilirubin in serum of neonates, with use of bilirubin oxidase. Clin. Chem. 33 (1987) 1822-1825
32. Scatchard G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51 (1949) 660-664
33. Levine R.L. Fluorescence-quenching studies of the binding of bilirubin to albumin. Clin. Chem. 23 (1977) 2292-2301
34. Seger C., Sturm S., Haslinger E., and Stuppner H. A new cucurbitacin D related 16,23-epoxy derivatives and its isomerisation products. Org. Lett. 6 (2004) 633-636
35. Sturm S., and Stuppner H. Analysis of cucurbitacins in medicinal plants by high-pressure liquid chromatography-mass spectrometry. Phytochem. Anal. 11 (2000) 121-127
36. Greige-Gerges H., Abou Khalil R., Chahine R., Haddad C., Harb W., and Ouaini N. Effect of cucurbitacins on bilirubin-albumin binding in human plasma. Life Sci. 80 (2007) 579-585
37. Mushahid Khan M., and Tayyab S. Understanding the role of internal lysine residues of serum albumins in conformational stability and bilirubin binding. Biochim. Biophys. Acta 1545 (2001) 263-277
38. Athar H., Ahmad N., Tayyab S., and Qasim M.A. Use of fluorescence enhancement technique to study bilirubin-albumin interaction. Int. J. Biol. Macromol. 25 (1999) 353-358
39. Baroni S., Mattu M., Vannini A., Cipollone R., Aime S., Ascenzi P., and Fasano M. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. Eur. J. Biochem. 268 (2001) 6214-6220
40. Tanaka N., Nishizawa H., and Kungi S. Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation. Biochim. Biophys. Acta 1338 (1997) 13-20
41. Mushahid Khan M., and Tayyab S. On the modulation of photoinduced fluorescence enhancement and conformational stability of albumin-bound bilirubin: effect of ε-NH2 groups blocking and chloroform binding. Biochim. Biophys. Acta 1523 (2000) 147-153
42. Kragh-Hansen U. Structure and ligand properties of human serum albumin. Dan Med. Bull. 37 (1990) 57-84
43. Hushcha T.O., Luik A.I., and Naboka Y.N. Conformation changes of albumin in its interaction with physiologically active compounds as studied by quasi-elastic light scattering spectroscopy and ultrasonic method. Talanta 53 (2000) 29-34